Filter
1929
Filtered Results: 1929
Text search:
Africa
Center
for
Disease
Control
and
Prevention
Featured
Recommendations
181
New Publications
462
Language
Document type
No document type
1050
Studies & Reports
412
Guidelines
217
Manuals
110
Strategic & Response Plan
55
Fact sheets
32
Training Material
26
Situation Updates
19
Resource Platforms
3
Infographics
3
App
1
Online Courses
1
Countries / Regions
Global
75
Liberia
72
Ethiopia
70
Africa
62
Kenya
57
Sierra Leone
56
Rwanda
45
Nigeria
43
Uganda
35
India
33
Tanzania
32
Malawi
30
Zambia
29
Mozambique
26
South Africa
23
Guinea
22
Senegal
22
Congo, Democratic Republic of
18
Ghana
18
Latin America and the Carribbean
18
Nepal
17
Lesotho
17
Zimbabwe
16
South Sudan
15
Middle East and North Africa
15
West and Central Africa
14
Western and Central Europe
14
Asia
14
Burkina Faso
13
Syria
13
Ukraine
13
Bangladesh
11
Namibia
11
Yemen
11
East and Southern Africa
11
Brazil
10
Angola
10
Cambodia
9
Eastern Europe
9
Cameroon
7
Philippines
7
Botswana
7
South–East Asia Region
7
Russia
7
Central African Republic
6
Eswatini/ Swaziland
6
Myanmar / Burma
6
Guinea-Bissau
5
Haiti
5
Pakistan
5
Somalia
4
Jordan
4
Afghanistan
4
Thailand
4
Indonesia
4
Eastern Europe and Central Asia
4
Mali
3
Germany
3
China
3
Benin
3
Burundi
3
Madagascar
3
Albania
3
Vietnam
3
Japan
3
USA
2
Turkey
2
Libya
2
Sri Lanka
2
Venezuela
2
Armenia
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Lebanon
1
Egypt
1
Chad
1
Malaysia
1
Papua New Guinea
1
Sudan
1
Argentina
1
North Macedonia
1
Honduras
1
Greece
1
Mexico
1
Chile
1
Western Pacific Region
1
Paraguay
1
Palestine
1
Italy
1
Southern Africa
1
Canada
1
Tajikistan
1
Qatar
1
Georgia
1
North America
1
Belgium
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
604
Clinical Guidelines
174
Public Health
122
Women & Child Health
98
Key Resources
83
Capacity Building
40
Pharmacy & Technologies
21
Toolboxes
HIV
201
COVID-19
176
TB
130
Mental Health
124
Ebola
102
AMR
92
Planetary Health
83
Rapid Response
73
NTDs
58
Caregiver
46
Global Health Education
44
Disability
39
NCDs
34
Conflict
31
Refugee
30
Health Financing Toolbox
30
Pharmacy
29
Zika
16
Natural Hazards
15
Cholera
12
Polio
6
Specific Hazards
5
Social Ethics
4
South Sudan
1
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like ... occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
For over 23 years, CDC has collaborated in Malawi with local and international partners to strengthen health systems. The office works to prevent, detect ... respond to diseases. Efforts include building healthcare workforce capacity, strengthening laboratory systems, and increasing the capacity of surveillance and health information systems. CDC also implements high-impact HIV and tuberculosis programs through the President's Emergency Plan for AIDS Relief and supports malaria control activities under the U.S. President's Malaria Initiative.
Africa CDC Non Communicable Diseases, Injuries Prevention and Control and Mental Health Promotion Strategy
recommended
Non-communicable diseases (NCDs) & injuries and mental health conditions constitute a serious impediment to achieving the vision of Agenda 2063 to build an integrated, prosperous, ... peaceful Africa driven by its own citizens. Each year, these conditions cause millions of premature deaths and disabled lives across Africa. These conditions also lead to annual economic loss of multiple billion US-Dollars. Their burden both in terms of disease morbidity/mortality and socio-economic impact is increasing.
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Di... Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonization (AMRH) Initiative, and the World Health Organisation’s (WHO) African Vaccine Regulatory Forum (AVAREF) to enable and provide support for an effective regulatory framework for COVID-19 Vaccines in Africa.
https://doi.org/10.1371/journal.pntd.0002439
South Sudan has a high burden – among the highest in sub-Saharan Africa – of neglected tropical diseases (NTDs). This adversely affects the health ...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequenc...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, ... b.) there is a high prevalence of HIV infection, both known
and undiagnosed, in settings such as prisons, jails, other
detention centers, and drug rehabilitation centers.
African Union and the Africa Centers for Disease Con... and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine
10 March 2021
Executive summary On 27th and 28th April 2021, the division of Disease Control and ... in collaboration with Public Health England, organized a virtual consultative meeting as part of the consultations with Member States and partners for the development of the Africa CDC five years strategic plan for the prevention and control of Non-communicable Diseases … Report: Expert and stakeholder virtual consultation meeting to develop the Africa CDC Non-Communicable Diseases and Mental Health Strategy
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the <... remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improve leishmaniasis prevention and control based on robust surveillance in humans, animals, and vectors, and to increase public awareness following a one health approach.
AstraZeneca-SKBio in South Korea and Serum Institute of India
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associa...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause ...
Accessed: 02.04.2020
This policy brief draws from the latest evidence on the impact of vaccination program start date and vaccine rollout rates on health benefits. The objective is to support policymakers on decisions to procure COVID-19 vaccines ... roll out vaccination programmes in countries, especially those
where large proportions of the population remain unvaccinated.
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment ... to avert viral transmission;
Sentinel surveillance in high-risk populations to detect and track both presymptomatic and asymptomatic cases; and
Wastewater surveillance to monitor early environmental signs of virus transmission and identify communities where targeted interventions can be implemented to decrease transmission.
